首页> 外文期刊>Industrial and organizational psychology >Stability of Fish Oil in Calcium Alginate Microcapsules Cross-Linked by In Situ Internal Gelation During Spray Drying
【24h】

Stability of Fish Oil in Calcium Alginate Microcapsules Cross-Linked by In Situ Internal Gelation During Spray Drying

机译:喷雾干燥过程中原位内凝胶的藻酸钙微胶囊中鱼油稳定性

获取原文
获取原文并翻译 | 示例
           

摘要

Microencapsulating bioactive compounds, such as polyunsaturated fatty acids (PUFA), in dry cross-linked alginate serves to enhance their shelf life, mask unwanted flavors and odors, facilitate their incorporation into food products, and provide an intestinal release mechanism. Alginate microencapsulation is challenging to implement at industrial scale, but a recently developed process provides scalability by accomplishing alginate cross-linking in situ during spray drying. This study investigated how formulation variables affect the oxidative stability of fish oil in cross-linked alginate microcapsules (CLAMs) prepared via this industrially scalable process. Storage stability of PUFA from fish oil was prolonged by microencapsulation in CLAMs, relative to nonencapsulated fish oil. Neither the choice of emulsifier (Tween 80 or whey protein isolate) nor the extent of alginate cross-linking influenced the duration of storage stability of eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). However, the retention of EPA and DHA during spray drying was significantly lower for CLAMs prepared with Tween 80. The addition of n-octenyl succinic anhydride (OSA) modified starch into spray-drying formulations improved the storage stability of microencapsulated fish oil. With increasing OSA-starch content in CLAMs, surface oil content decreased, particle size and powder yield increased, and PUFA storage stability increased. Despite OSA-starch being the majority component, OSA-starch CLAMs exhibited gastrointestinal release properties more akin to CLAMs than control OSA-starch microcapsules. OSA-starch CLAMs retained fish oil cargo in simulated gastric fluid and released it in simulated intestinal fluid, while OSA-starch microcapsules completely released cargo in either fluid. Overall, OSA-starch CLAMs show promise as an industrial-scale system for stabilizing PUFA while providing an enteric delivery mechanism.
机译:微胶囊化的生物活性化合物如多不饱和脂肪酸(PUFA),在干交联藻酸盐中用于增强其保质期,面膜不需要的香料和气味,促进其掺入食品中,并提供肠道释放机制。藻酸盐微胶囊综合性是在工业规模实施的具有挑战性,但最近开发的过程通过在喷雾干燥期间完成原位的藻酸盐交联来提供可扩展性。本研究研究了配方变量如何影响通过该工业上可扩展的方法制备的交联藻酸盐微胶囊(蛤蜊)中鱼油的氧化稳定性。通过蛤蜊中微胶质沉积的PUFA的储存稳定性,相对于未封装的鱼油,微胶囊延长。乳化剂(吐温80或乳清蛋白分离物)的选择也不是藻酸盐交联的程度,影响了eicosapentaeno酸(EPA)和二十二碳六烯酸(DHA)的储存稳定性的持续时间。然而,对于用吐温80的蛤蜊保留喷雾干燥期间的保留率显着降低。将N-辛烯基琥珀酸酐(OSA)改性淀粉添加到喷雾干燥制剂中,改善了微胶质鱼油的储存稳定性。随着蛤蜊中的OSA-淀粉含量增加,表面油含量下降,粒度和粉末产量增加,PUFA储存稳定性增加。尽管OSA-淀粉是大多数组分,但OSA-淀粉蛤表现出胃肠道释放性质,而不是对照OSA-淀粉微胶囊来涂抹于蛤蜊。 OSA-淀粉蛤在模拟胃液中保留了鱼油货物,并在模拟肠道液中释放出来,而OSA-淀粉微胶囊完全释放出在任何一种流体中的货物。总体而言,OSA-淀粉蛤展示了承诺作为稳定PUFA的工业规模系统,同时提供肠运机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号